Standigm

Standigm is a leading workflow AI-driven pharmaceutical manufacturing company dedicated to revolutionizing drug discovery. Standigm leverages proprietary AI platforms that span from novel target identification to lead generation, creating commercially valuable drug pipelines. Founded in 2015, Standigm has established an early-stage drug discovery workflow AI to generate First-in-Class lead compounds efficiently.

Standigm is committed to full-stack, AI-driven industrializing drug discovery. Through DarkMolFactory™, the company has automated the molecular design workflow, extending automation across the entire drug discovery process using Standigm AI platforms. These include Standigm ASK™ for target discovery, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing.

Standigm's primary address is 3rd Floor, 70 Nonhyeon-ro 85-gil, Gangnam-gu Seoul, 06234, KR, with additional locations in Cambridge, England CB1 2JH, GB, and One Broadway, 14th Floor, Cambridge, MA 02142, US. We invite Standigm's management to create a customized and exclusive company showcase and product listing on our platform to further enhance its market presence.